Table 1.

Demographics of normal and HAART-treated HIV⁺ Nonsmokers.

Sample ID	Age	Gender/ethnicity	HIV status	Phenotype	Viral load (copies/ml)	Blood CD4 (cell # per µl)	HAART regimen
1	22	M (African)	−	NS	NA	NA	NA
2	50	M (African)	−	NS	NA	NA	NA
3	43	F (African)	−	NS	NA	NA	NA
4	42	F (Caucasian)	−	NS	NA	NA	NA
5	53	F (other)	+	NS	Detected, < 20	1106	Elvitegravir/Cobicistat/Emtricitabine/Tenofovir alafenamide (Genvoya)
6	19	M (African)	+	NS	Detected, < 20	500	Efavirenz, emtricitabine, and tenofovir disoproxil fumarate (Atripla)
7	43	M (Hispanic)	+	NS	Not detected	1080	Elvitegravir/Cobicistat/Emtricitabine/Tenofovir alafenamide (Genvoya)
8	45	M (African)	+	NS	Not detected	750	Emtricitabine, rilpivirine, and tenofovir disoproxil fumarate (Complera)

NS nonsmoker, NA not applicable.